Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KR230109 Cream in Patients with Acne Vulgaris
CTR20255054Phase 2Active
- Sponsor
- Jiangxi Kerui Pharmaceutical Co., Ltd.
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of KR230109 in acne vulgaris, sponsored by Jiangxi Kerui Pharmaceutical Co., Ltd.. Started Feb 2026; status: active.
02
Drugs
KR230109
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on CTR20255054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20255054.